Investig Clin Urol.
2023 Sep;64(5):419-421. 10.4111/icu.20230185.
Poly (ADP-ribose) polymerase inhibitor: A new horizon in advanced prostate cancer treatment
- Affiliations
-
- 1Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- 2Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea
- 3Samsung Genome Institute, Samsung Medical Center, Seoul, Korea
- KMID: 2545558
- DOI: http://doi.org/10.4111/icu.20230185
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
- Melatonin Induces Apoptotic Cell Death via p53 in LNCaP Cells
- Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder
- Cisplatin induces primary necrosis through poly(ADP-ribose) polymerase 1 activation in kidney proximal tubular cells
- BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies
